Rare diseases
Investigational molecules
Locations
Back to Germany13 clinical trials in Herdecke, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyStudy of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine
GermanyStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
GermanyStudy on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase
GermanyStudy on Vinblastine for Children and Adolescents with Standard Risk ALK-Positive Anaplastic Large Cell Lymphoma
GermanyStudy on Ewing Sarcoma Treatment with Vinorelbine and Drug Combination for Patients with Primary and Disseminated Disease
GermanyStudy of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia
GermanyStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination
GermanyStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
GermanyGermanyStudy on Ganaxolone for Children and Adults with Epilepsy Related to Tuberous Sclerosis Complex
GermanyStudy Comparing Carboplatin and Cisplatin for Patients with Extracranial Malignant Germ Cell Tumors
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lymphoma and leukemia treatments in children and adolescents, including studies of mature B-cell lymphomas and acute lymphoblastic leukemia. Clinical trials are evaluating new therapeutic approaches combining standard chemotherapy with targeted immunotherapy.
Researchers are exploring personalized treatment approaches based on genetic markers and response assessments.
Comprehensive studies of brain tumors, with particular focus on ependymoma and medulloblastoma in young patients. These trials aim to improve surgical outcomes and evaluate novel treatment combinations including radiation therapy and chemotherapy protocols.
Research emphasizes improving survival rates while minimizing long-term side effects.
Specialized research on germ cell tumors and rare lymphomas, investigating optimal treatment strategies and comparing different chemotherapy regimens. These trials are particularly focused on pediatric and adolescent populations.
International collaboration enables comprehensive evaluation of treatment effectiveness for rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
